Ann Van Driessche

1.3k total citations
16 papers, 536 citations indexed

About

Ann Van Driessche is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Ann Van Driessche has authored 16 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Immunology and 7 papers in Oncology. Recurrent topics in Ann Van Driessche's work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (7 papers) and RNA Interference and Gene Delivery (7 papers). Ann Van Driessche is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (7 papers) and RNA Interference and Gene Delivery (7 papers). Ann Van Driessche collaborates with scholars based in Belgium, Netherlands and United Kingdom. Ann Van Driessche's co-authors include Zwi Berneman, Viggo Van Tendeloo, Christophe De Block, L. Van Gaal, Griet Nijs, Peter Ponsaerts, Dirk R. Van Bockstaele, Nathalie Cools, Barbara Stein and Marc Lenjou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ann Van Driessche

16 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Van Driessche Belgium 9 266 211 175 133 65 16 536
Antonella Stella Italy 5 217 0.8× 212 1.0× 37 0.2× 114 0.9× 63 1.0× 7 435
Véronique Bajzik United States 9 229 0.9× 78 0.4× 128 0.7× 53 0.4× 23 0.4× 10 612
Mitsue Shimada Japan 8 294 1.1× 95 0.5× 216 1.2× 77 0.6× 26 0.4× 11 560
Kanji Nagahama Japan 9 247 0.9× 89 0.4× 71 0.4× 46 0.3× 22 0.3× 26 460
Nadine Pouw Netherlands 10 286 1.1× 132 0.6× 407 2.3× 208 1.6× 18 0.3× 20 560
Fleur S. Kleijwegt Netherlands 9 539 2.0× 84 0.4× 70 0.4× 265 2.0× 126 1.9× 10 836
I Janatková Czechia 13 153 0.6× 77 0.4× 47 0.3× 66 0.5× 10 0.2× 32 412
Yuji Nishio Japan 14 170 0.6× 71 0.3× 87 0.5× 164 1.2× 13 0.2× 38 528
Gennett M. Myhre United States 6 91 0.3× 125 0.6× 67 0.4× 114 0.9× 7 0.1× 6 453
Vincenzo Mirenda United Kingdom 12 316 1.2× 69 0.3× 76 0.4× 113 0.8× 43 0.7× 19 599

Countries citing papers authored by Ann Van Driessche

Since Specialization
Citations

This map shows the geographic impact of Ann Van Driessche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Van Driessche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Van Driessche more than expected).

Fields of papers citing papers by Ann Van Driessche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Van Driessche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Van Driessche. The network helps show where Ann Van Driessche may publish in the future.

Co-authorship network of co-authors of Ann Van Driessche

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Van Driessche. A scholar is included among the top collaborators of Ann Van Driessche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Van Driessche. Ann Van Driessche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Ledeganck, Kristien J., Benedicte Y. De Winter, Ann Van Driessche, et al.. (2013). Magnesium loss in cyclosporine-treated patients is related to renal epidermal growth factor downregulation. Nephrology Dialysis Transplantation. 29(5). 1097–1102. 29 indexed citations
3.
Driessche, Ann Van, et al.. (2013). TETANUS: A DIAGNOSTIC CHALLENGE IN THE WESTERN WORLD. Acta Clinica Belgica. 68(6). 416–420. 4 indexed citations
4.
Berneman, Zwi, Ann Van de Velde, Sébastien Anguille, et al.. (2012). WT1-targeted dendritic cell vaccination as a postremission treatment to prevent or delay relapse in acute myeloid leukemia.. Journal of Clinical Oncology. 30(15_suppl). 2506–2506. 4 indexed citations
5.
Driessche, Ann Van, et al.. (2012). Cyclic vomiting syndrome: case report and short review of the literature.. PubMed. 67(2). 123–6. 7 indexed citations
6.
Driessche, Ann Van, Zwi Berneman, & Viggo Van Tendeloo. (2012). Active Specific Immunotherapy Targeting the Wilms' Tumor Protein 1 (WT1) for Patients with Hematological Malignancies and Solid Tumors: Lessons from Early Clinical Trials. The Oncologist. 17(2). 250–259. 69 indexed citations
7.
Berneman, Zwi, Ann Van de Velde, Sébastien Anguille, et al.. (2011). 161 Dendritic Cell Vaccination in Acute Myeloid Leukemia. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(Supplement 2). 67–67. 1 indexed citations
8.
9.
Driessche, Ann Van, et al.. (2009). Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review.. PubMed. 67(11). 376–87. 120 indexed citations
10.
Berneman, Zwi, Ann Van de Velde, Ann Van Driessche, et al.. (2008). Immunogenicity and Antileukemic Activity of Dendritic Cells Electroporated with Wilms’ Tumor WT1 mRNA: A Phase I/II Trial in Acute Myeloid Leukemia. Blood. 112(11). 830–830. 2 indexed citations
11.
Smits, Evelien, Peter Ponsaerts, Ann Van Driessche, et al.. (2007). Proinflammatory response of human leukemic cells to dsRNA transfection linked to activation of dendritic cells. Leukemia. 21(8). 1691–1699. 37 indexed citations
12.
Berneman, Zwi, Ann Van Driessche, Ann Van de Velde, et al.. (2007). Vaccination of Acute Myeloid Leukemia Patients with Dendritic Cells Electroporated with mRNA Encoding the Wilms’ Tumor Protein WT1: A Phase I/II Trial.. Blood. 110(11). 158–158. 2 indexed citations
13.
Driessche, Ann Van, Li Gao, Hans J. Stauss, et al.. (2005). Antigen-specific cellular immunotherapy of leukemia. Leukemia. 19(11). 1863–1871. 47 indexed citations
14.
Driessche, Ann Van, Peter Ponsaerts, Dirk R. Van Bockstaele, Viggo Van Tendeloo, & Zwi Berneman. (2005). Messenger RNA electroporation: an efficient tool in immunotherapy and stem cell research.. SHILAP Revista de lepidopterología. 43(4). 213–6. 21 indexed citations
15.
Ponsaerts, Peter, Viggo Van Tendeloo, Nathalie Cools, et al.. (2002). mRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation. Leukemia. 16(7). 1324–1330. 46 indexed citations
16.
Ponsaerts, Peter, Nathalie Cools, Ann Van Driessche, et al.. (2002). Messenger RNA Electroporation of Human Monocytes, Followed by Rapid In Vitro Differentiation, Leads to Highly Stimulatory Antigen-Loaded Mature Dendritic Cells. The Journal of Immunology. 169(4). 1669–1675. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026